Isaac E. Ciechanover
2014
In 2014, Isaac E. Ciechanover earned a total compensation of $2.6M as Chief Executive Officer at Atara Biotherapeutics, a 355% increase compared to previous year.
Compensation breakdown
| Bonus | $420,100 |
|---|---|
| Option Awards | $907,238 |
| Salary | $410,825 |
| Stock Awards | $812,236 |
| Other | $4,890 |
| Total | $2,555,289 |
Ciechanover received $907.2K in option awards, accounting for 36% of the total pay in 2014.
Ciechanover also received $420.1K in bonus, $410.8K in salary, $812.2K in stock awards and $4.9K in other compensation.
Rankings
In 2014, Isaac E. Ciechanover's compensation ranked 3,575th out of 13,032 executives tracked by ExecPay. In other words, Ciechanover earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,575 out of 13,032 | 73rd |
Division Manufacturing | 1,258 out of 4,967 | 75th |
Major group Chemicals And Allied Products | 409 out of 1,690 | 76th |
Industry group Drugs | 316 out of 1,369 | 77th |
Industry Biological Products, Except Diagnostic Substances | 49 out of 241 | 80th |
Source: SEC filing on April 29, 2016.
Ciechanover's colleagues
We found two more compensation records of executives who worked with Isaac E. Ciechanover at Atara Biotherapeutics in 2014.